ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 191924 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 191924; 2) Community: the network communities that were significantly associated with the response to NSC 191924; 3) Molecule: the relationships between components within communities and NSC 191924; 4) MDR: the compounds that were significantly associated with the NSC 191924.

NSC Compound Enrichment Correlation
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0235234559682125 0.36317394
NSC 126228 Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0235234559682125 0.28001449
NSC 129757 Null 0.0235234559682125 0.080072095
NSC 129790 Null 0.0235234559682125 0.28408808
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.0235234559682125 0.15076714
NSC 303861 L-Cysteine analog 0.0235234559682128 0.41640667
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0235234559682128 0.15922445
NSC 339137 PHYSALOLACTONE 0.0235234559682128 0.39278802
NSC 34757 Melicopidine 0.0235234559682128 0.34149162
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0235234559682128 0.29120972
Total:137  Current:84    [First] [Prev] [Next] [Last]